Risk Factors for Changes in Bone Mineral Density and the Effect of Antiosteoporosis Management After Renal Transplantation

H. J. Ahn, H. J. Kim, YuSeun Kim, M. S. Kim, K. H. Huh, J. H. Kim, J. H. Lee, K. O. Jeon, S. I. Kim

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Using the pretransplant bone mineral density (BMD) data records of renal recipients, we retrospectively examined risk factors affecting posttransplant changes in BMD and the effect of antiosteoporosis management. For 294 kidney transplant recipients from January 1996 to September 2003, BMD values were expressed as spine and femur T-scores. Gender, age, pretransplant diabetes, blood type compatibility, mode and duration of dialysis, and previous transplantation were considered to be variables affecting BMD changes. T-test or ANOVA was used to compare risk factors. At the time of transplantation, mean spine T-scores were significantly lower among the retransplant group. Mean femur T-scores were significantly lower among the retransplant group, older patients (older than 45 years), and female recipients. Prolonged hemodialysis (>12 months) and retransplant were risk factors for BMD loss during the first year posttransplant. Early application of antiosteoporosis management was effective to ameliorate posttransplant BMD loss. However, antiosteoporosis management after 1 year posttransplant was relatively ineffective. Pretransplant evaluation of BMD and the possibility of significant BMD loss during the first posttransplant year should not be overlooked. Prophylaxis against bone loss and treatment should be started as soon as possible after transplantation for recipients with either normal or abnormal pretransplant BMD.

Original languageEnglish
Pages (from-to)2074-2076
Number of pages3
JournalTransplantation Proceedings
Volume38
Issue number7
DOIs
Publication statusPublished - 2006 Sep 1

Fingerprint

Kidney Transplantation
Bone Density
Transplantation
Femur
Spine
Kidney
Renal Dialysis
Dialysis
Analysis of Variance
Bone and Bones

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Cite this

Ahn, H. J. ; Kim, H. J. ; Kim, YuSeun ; Kim, M. S. ; Huh, K. H. ; Kim, J. H. ; Lee, J. H. ; Jeon, K. O. ; Kim, S. I. / Risk Factors for Changes in Bone Mineral Density and the Effect of Antiosteoporosis Management After Renal Transplantation. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 7. pp. 2074-2076.
@article{38cda70856ee4b509724355931cd0d03,
title = "Risk Factors for Changes in Bone Mineral Density and the Effect of Antiosteoporosis Management After Renal Transplantation",
abstract = "Using the pretransplant bone mineral density (BMD) data records of renal recipients, we retrospectively examined risk factors affecting posttransplant changes in BMD and the effect of antiosteoporosis management. For 294 kidney transplant recipients from January 1996 to September 2003, BMD values were expressed as spine and femur T-scores. Gender, age, pretransplant diabetes, blood type compatibility, mode and duration of dialysis, and previous transplantation were considered to be variables affecting BMD changes. T-test or ANOVA was used to compare risk factors. At the time of transplantation, mean spine T-scores were significantly lower among the retransplant group. Mean femur T-scores were significantly lower among the retransplant group, older patients (older than 45 years), and female recipients. Prolonged hemodialysis (>12 months) and retransplant were risk factors for BMD loss during the first year posttransplant. Early application of antiosteoporosis management was effective to ameliorate posttransplant BMD loss. However, antiosteoporosis management after 1 year posttransplant was relatively ineffective. Pretransplant evaluation of BMD and the possibility of significant BMD loss during the first posttransplant year should not be overlooked. Prophylaxis against bone loss and treatment should be started as soon as possible after transplantation for recipients with either normal or abnormal pretransplant BMD.",
author = "Ahn, {H. J.} and Kim, {H. J.} and YuSeun Kim and Kim, {M. S.} and Huh, {K. H.} and Kim, {J. H.} and Lee, {J. H.} and Jeon, {K. O.} and Kim, {S. I.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.transproceed.2006.06.106",
language = "English",
volume = "38",
pages = "2074--2076",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7",

}

Risk Factors for Changes in Bone Mineral Density and the Effect of Antiosteoporosis Management After Renal Transplantation. / Ahn, H. J.; Kim, H. J.; Kim, YuSeun; Kim, M. S.; Huh, K. H.; Kim, J. H.; Lee, J. H.; Jeon, K. O.; Kim, S. I.

In: Transplantation Proceedings, Vol. 38, No. 7, 01.09.2006, p. 2074-2076.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk Factors for Changes in Bone Mineral Density and the Effect of Antiosteoporosis Management After Renal Transplantation

AU - Ahn, H. J.

AU - Kim, H. J.

AU - Kim, YuSeun

AU - Kim, M. S.

AU - Huh, K. H.

AU - Kim, J. H.

AU - Lee, J. H.

AU - Jeon, K. O.

AU - Kim, S. I.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Using the pretransplant bone mineral density (BMD) data records of renal recipients, we retrospectively examined risk factors affecting posttransplant changes in BMD and the effect of antiosteoporosis management. For 294 kidney transplant recipients from January 1996 to September 2003, BMD values were expressed as spine and femur T-scores. Gender, age, pretransplant diabetes, blood type compatibility, mode and duration of dialysis, and previous transplantation were considered to be variables affecting BMD changes. T-test or ANOVA was used to compare risk factors. At the time of transplantation, mean spine T-scores were significantly lower among the retransplant group. Mean femur T-scores were significantly lower among the retransplant group, older patients (older than 45 years), and female recipients. Prolonged hemodialysis (>12 months) and retransplant were risk factors for BMD loss during the first year posttransplant. Early application of antiosteoporosis management was effective to ameliorate posttransplant BMD loss. However, antiosteoporosis management after 1 year posttransplant was relatively ineffective. Pretransplant evaluation of BMD and the possibility of significant BMD loss during the first posttransplant year should not be overlooked. Prophylaxis against bone loss and treatment should be started as soon as possible after transplantation for recipients with either normal or abnormal pretransplant BMD.

AB - Using the pretransplant bone mineral density (BMD) data records of renal recipients, we retrospectively examined risk factors affecting posttransplant changes in BMD and the effect of antiosteoporosis management. For 294 kidney transplant recipients from January 1996 to September 2003, BMD values were expressed as spine and femur T-scores. Gender, age, pretransplant diabetes, blood type compatibility, mode and duration of dialysis, and previous transplantation were considered to be variables affecting BMD changes. T-test or ANOVA was used to compare risk factors. At the time of transplantation, mean spine T-scores were significantly lower among the retransplant group. Mean femur T-scores were significantly lower among the retransplant group, older patients (older than 45 years), and female recipients. Prolonged hemodialysis (>12 months) and retransplant were risk factors for BMD loss during the first year posttransplant. Early application of antiosteoporosis management was effective to ameliorate posttransplant BMD loss. However, antiosteoporosis management after 1 year posttransplant was relatively ineffective. Pretransplant evaluation of BMD and the possibility of significant BMD loss during the first posttransplant year should not be overlooked. Prophylaxis against bone loss and treatment should be started as soon as possible after transplantation for recipients with either normal or abnormal pretransplant BMD.

UR - http://www.scopus.com/inward/record.url?scp=33846034850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846034850&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.06.106

DO - 10.1016/j.transproceed.2006.06.106

M3 - Article

C2 - 16980003

AN - SCOPUS:33846034850

VL - 38

SP - 2074

EP - 2076

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 7

ER -